Tech Titans Surge with Massive Trading Volumes: Tesla Leads the Charge!
Market BriefMonday, May 12, 2025 6:31 pm ET
2min read1. Tesla (Nasdaq: TSLA)
Tesla surged by 6.75%, with the trading volume of 35.67B. Tesla faces inquiries from US agencies about its autonomous taxi plans, with analysts citing FSD technology as a major growth driver. Domestic Tesla exports nearly 30,000 units in April, showing a significant month-on-month increase.
2. Nvidia (Nasdaq: NVDA)
Nvidia gained solidly by 5.44%, with the trading volume of 27.29B. NVIDIA's upcoming RTX Titan Ada prototype card shows a 15% performance boost despite release issues. The company faces substantial revenue losses due to Trump's tariffs, and plans to launch lower-spec H20 chips for China in July.
3. Amazon (Nasdaq: AMZN)
Amazon.Com surged by 8.07%, with the trading volume of 15.62B. Amazon-backed Scale AI plans to expand into the Middle East by opening an office in Saudi Arabia. Amazon introduces a new robot named "Vulcan," potentially creating hundreds of tech jobs.
4. Meta Platforms (Nasdaq: META)
Meta Platforms surged by 7.92%, with the trading volume of 13.86B. Meta is developing a standalone AI model application for its smart glasses, which are set to include facial recognition features. Additionally, Meta has opened Quest headset cameras to support mixed reality application development.
5. Apple (Nasdaq: AAPL)
Apple surged by 6.32%, with the trading volume of 13.34B. Apple plans to develop AI-based tools to extend device battery life and has announced another price cut on iPhones in China ahead of the "6.18" shopping festival. Morgan Stanley highlights uncertainty in Apple's services business, emphasizing Google's collaboration and AI as future determinants.
6. Palantir Technologies (NYSE: PLTR)
Palantir Technologies gained mildly by 0.99%, with the trading volume of 11.06B. Wedbush identifies Nvidia, Microsoft, Apple, Alibaba, and Baidu among the top 30 tech companies set to shape AI's future.
7. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.40%, with the trading volume of 10.15B. Microsoft is renegotiating multimillion-dollar partnership terms with OpenAI regarding IPO plans, profit sharing adjustments, and access to AI technology. Microsoft's development plans for Windows include renaming "Developer Settings" to "Advanced Settings" to integrate additional features.
8. Netflix (Nasdaq: NFLX)
Netflix dipped mildly by -2.65%, with the trading volume of 7.20B. Netflix reported a trading volume of $7.202 billion on May 12.
9. Alphabet (Nasdaq: GOOGL)
Alphabet gained solidly by 3.74%, with the trading volume of 6.95B. Google launches AI Future Fund for startup cooperation; Wedbush removed Alphabet from top investment list due to AI impact uncertainty; Google's iOS app icon redesigns with new gradient colors; UniCredit partners with Google Cloud to accelerate digital transformation.
10. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained mildly by 2.93%, with the trading volume of 6.66B. Eli Lilly reported that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a trial. In head-to-head research, Eli Lilly's Tirzepatide achieved better weight loss results compared to Semaglutide, surpassing key endpoints in the SURMOUNT-5 study.
Tesla surged by 6.75%, with the trading volume of 35.67B. Tesla faces inquiries from US agencies about its autonomous taxi plans, with analysts citing FSD technology as a major growth driver. Domestic Tesla exports nearly 30,000 units in April, showing a significant month-on-month increase.
2. Nvidia (Nasdaq: NVDA)
Nvidia gained solidly by 5.44%, with the trading volume of 27.29B. NVIDIA's upcoming RTX Titan Ada prototype card shows a 15% performance boost despite release issues. The company faces substantial revenue losses due to Trump's tariffs, and plans to launch lower-spec H20 chips for China in July.
3. Amazon (Nasdaq: AMZN)
Amazon.Com surged by 8.07%, with the trading volume of 15.62B. Amazon-backed Scale AI plans to expand into the Middle East by opening an office in Saudi Arabia. Amazon introduces a new robot named "Vulcan," potentially creating hundreds of tech jobs.
4. Meta Platforms (Nasdaq: META)
Meta Platforms surged by 7.92%, with the trading volume of 13.86B. Meta is developing a standalone AI model application for its smart glasses, which are set to include facial recognition features. Additionally, Meta has opened Quest headset cameras to support mixed reality application development.
5. Apple (Nasdaq: AAPL)
Apple surged by 6.32%, with the trading volume of 13.34B. Apple plans to develop AI-based tools to extend device battery life and has announced another price cut on iPhones in China ahead of the "6.18" shopping festival. Morgan Stanley highlights uncertainty in Apple's services business, emphasizing Google's collaboration and AI as future determinants.
6. Palantir Technologies (NYSE: PLTR)
Palantir Technologies gained mildly by 0.99%, with the trading volume of 11.06B. Wedbush identifies Nvidia, Microsoft, Apple, Alibaba, and Baidu among the top 30 tech companies set to shape AI's future.
7. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.40%, with the trading volume of 10.15B. Microsoft is renegotiating multimillion-dollar partnership terms with OpenAI regarding IPO plans, profit sharing adjustments, and access to AI technology. Microsoft's development plans for Windows include renaming "Developer Settings" to "Advanced Settings" to integrate additional features.
8. Netflix (Nasdaq: NFLX)
Netflix dipped mildly by -2.65%, with the trading volume of 7.20B. Netflix reported a trading volume of $7.202 billion on May 12.
9. Alphabet (Nasdaq: GOOGL)
Alphabet gained solidly by 3.74%, with the trading volume of 6.95B. Google launches AI Future Fund for startup cooperation; Wedbush removed Alphabet from top investment list due to AI impact uncertainty; Google's iOS app icon redesigns with new gradient colors; UniCredit partners with Google Cloud to accelerate digital transformation.
10. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained mildly by 2.93%, with the trading volume of 6.66B. Eli Lilly reported that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a trial. In head-to-head research, Eli Lilly's Tirzepatide achieved better weight loss results compared to Semaglutide, surpassing key endpoints in the SURMOUNT-5 study.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet